Literature DB >> 33564986

Greater Pain Severity Is Associated with Worse Outcomes in Patients with Heart Failure.

Kent Y Feng1, Christopher M O'Connor2,3,4, Robert Clare3, Brooke Alhanti3, Ileana L Piña5, William E Kraus4, David J Whellan6, Robert J Mentz3,4.   

Abstract

We examined the relationship between pain severity and outcomes in patients with heart failure with reduced ejection fraction (HFrEF) in the HF-ACTION randomized controlled trial. Trends of health-related quality of life (HRQoL) measures grouped by patients' self-reported baseline bodily pain severity were compared using correlation tests, and the association between pain severity and clinical outcomes (including a primary composite endpoint of all-cause mortality and all-cause hospitalization) was assessed using multivariable adjusted analyses. Of the 2310 patients, 22.9% reported no pain, 45.8% very mild/mild, 24.9% moderate, and 6.4% severe/very severe. Greater pain severity was associated with worse HRQoL measures (EuroQoL-5D-3L and Kansas City Cardiomyopathy Questionnaire; both p < 0.0001). Compared to those reporting no pain, patients reporting severe/very severe pain had greater risk for the primary endpoint (adjusted hazard ratio 1.42, 95% confidence interval 1.11-1.83, p = 0.01). In patients with HFrEF, greater pain severity was associated with worse HRQoL and clinical outcomes. Trial Registration: NCT00047437.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Exercise; Health-related quality of life; Heart failure; Pain

Mesh:

Year:  2021        PMID: 33564986     DOI: 10.1007/s12265-021-10104-0

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  1 in total

1.  Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life.

Authors:  Christian Madelaire; Finn Gustafsson; Søren L Kristensen; Maria D'Souza; Lynne W Stevenson; Lars Kober; Christian Torp-Pedersen; Gunnar Gislason; Morten Schou
Journal:  JACC Heart Fail       Date:  2019-07       Impact factor: 12.035

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.